Amid range-bound trade today, here are the 3 biggest losing stocks

Published: September 22 2022, 21:00 GMT+0

Amid range-bound trade today, here are the 3 biggest losing stocks

A bad day for CureVac, lost 14.11%

Current market events are being influenced by ambiguous macro data as highly important Initial Jobless Claims data from United States beat analyst expectations of 218,000 with a reading of 213,000.

ProShares Ultra Bloomberg Natural Gas ended the session at $62.37, continuing its bearish run

Today's session continued down the same path: a tough session dominated by bearish sentiment left BOIL $9.85 lower, while setting a $59.92 to $70.42 session range.

-14.11%: CureVac lost 14.11% today, closed at $7.55

More of the same from today's session: early in today's session, CureVac dropped to $7.53 from $8.79 at the end of yesterday, before closing at $7.55. During the session, it lost 14.11%.
CureVac is currently trading with a market cap of $1.42 billion with an average daily volume of 289,783 shares. So far in 2022, it has been doing worse than the Nasdaq by 33.95%.

-13.26%: Novavax sheds 13.26% within $21.83 to $24.65 daily range

Today's session continued the recent downtrend: early in today's session, Novavax dropped to $21.83 from $25.87 at the end of yesterday, before closing at $22.44. During the session, it lost 13.26%.
Novavax has a market cap of $1.76 billion with an average daily trading volume of 3.63 million shares. So far in 2022, it has been under-performing the Nasdaq by 40.79%.

Back